HUTCHMED’s metastatic colorectal cancer treatment meets primary endpoint in Phase III trial

August 8, 2022
Sales and Marketing

HUTCHMED has announced that its global Phase III FRESCO-2 trial, evaluating the investigational use of fruquintinib, reached its primary endpoint …

Another “Winter crisis” on horizon for NHS without urgent action

August 8, 2022
Sales and Marketing

The NHS in England could face “very serious challenges coming down the track” without significant action tackling the emergency crisis …

SIGA will seek FDA approval of monkeypox treatment once data is available

August 8, 2022
Sales and Marketing

The CEO of SIGA Technologies has announced that they are planning to ask the FDA for approval and authorisation for …

Melanoma cells use ‘molecular drills’ to invade new tissues, research finds

August 8, 2022
Sales and Marketing

Scientists have identified a nerve cell gene that enables melanoma cells to branch out and invade new tissues. Research from …

F2G announce development and commercialisation for rare antifungal treatment

August 5, 2022
Medical Communications

F2G, a clinical-stage biopharmaceutical company, has announced that it can now soon bring a fourth antifungal class to the market. …

Societal CDMO wins tech transfer and production contract for HIV drug candidate

August 5, 2022
Medical Communications

Societal CDMO, a contract development and manufacturing organisation (CDMO) has been selected to provide CDMO services to support the ongoing …

Over 100,000 monkeypox vaccines procured, according to government

August 4, 2022
Business Services

Over 100,000 doses of the monkeypox vaccine have been acquired in order to combat the spread of the virus, the …

UK health officials identify new symptoms of monkeypox

August 4, 2022
Business Services

Health officials have identified a number of new monkeypox symptoms following the news that the outbreak was now a “public …

Medics in Ukraine work amid shelling and worsening health crisis

August 4, 2022
Business Services

Ukraine’s health emergency is worsening WHO have shared, as the conflict with Russia continues, and staff face burnout and increased …

NHS screening pilot for Hepatitis C

August 4, 2022
Business Services

Thousands will receive potentially life-saving treatment for Hepatitis C from the NHS, under a screening pilot. This is part of …

Fourth and oldest patient to be cured of HIV

July 28, 2022
Business Services

A 66 year old man has become the fourth person to be effectively cured of HIV infection following a stem …

Global monkeypox cases rise to 18,000

July 28, 2022
Business Services

WHO have shared that the window to stop the spread of monkeypox is closing, with cases currently doubling every two …

PCI Pharma Services announces multi-million dollar expansion to UK manufacturing facility

July 27, 2022
Research and Development

PCI has announced a significant expansion of its facility in Tredegar, Wales, UK, designed to help keep up to date …

Micronesia’s first COVID outbreak sees steep rise in cases

July 27, 2022
Research and Development

Micronesia’s first outbreak of COVID-19 has grown in one week to over 1,000 cases, causing significant alarm in the Pacific …

Updated NICE pre-eclampsia guidance

July 27, 2022
Research and Development

New NICE guidance has been released, recommending the routine use of placental growth factor (PIGF), based on testing in the …

MHRA grant marketing authorisation for sickle cell anaemia treatment

July 26, 2022
Manufacturing and Production

Global Blood Therapeutics (GBT) has announced the MHRA marketing authorisation for Oxbryta® (voxelotor) for the treatment of haemolytic anaemia due …

HealthTrackRx develops monkeypox-specific PCR test with next-day results

July 26, 2022
Manufacturing and Production

HealthTrackRx is now offering a molecular test for detection of the human monkeypox virus. The test was developed by the …

Shift in drinking patterns could lead to 150,000 more cases of disease in England

July 26, 2022
Manufacturing and Production

New modelling research carried out by the Institute of Alcohol Studies (IAS) and Health Lumen, has found that if alcohol …

CHMP issues positive recommendation to first and only biologic for asthma patients

July 26, 2022
Manufacturing and Production

AstraZeneca’s Tezspire (tezepelumab) has been recommended for marketing authorisation in the EU, as an add-on therapy in patients 12 years …

VistaGen’s social anxiety disorder treatment fails to meet primary endpoint in Phase III

July 25, 2022
Sales and Marketing

VistaGen Therapeutics has announced topline data from its Phase III PALISADE-1 trial which shows that PH94B, its nasal spray candidate …

The Gateway to Local Adoption Series

Latest content